Trial Profile
Evaluation of two Trizivir [abacavir]-based strategies of induction-maintenance in antiretroviral-naive HIV-infected patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Aug 2023
Price :
$35
*
At a glance
- Drugs Lamivudine/zidovudine/abacavir (Primary) ; Efavirenz; Lopinavir/ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 10 Jun 2009 Status changed from not stated to completed.
- 07 Feb 2006 New trial record.